
– Operates health and beauty stores and retail pharmacies, mainly in South Africa. Clicks and UniCare serve pharmacy customers, while Clicks stores also sell beauty and personal care products. The UPD wholesale business supplies the group’s pharmacies, independent pharmacies and private hospital groups.
– Operates health and beauty stores and retail pharmacies, mainly in South Africa. Clicks and UniCare serve pharmacy customers, while Clicks stores also sell beauty and personal care products. The UPD wholesale business supplies the group’s pharmacies, independent pharmacies and private hospital groups.– Sells medicines, beauty products and personal care goods through Clicks stores and pharmacies. Its retail business also includes UniCare pharmacies. The UPD wholesale business supplies medicines to the group’s pharmacies, independent pharmacies and private hospitals in South Africa.– Sells medicines, cosmetics and personal care products through Clicks stores and pharmacies in South Africa. UniCare runs specialist pharmacies. The group's UPD division supplies medicines to retail pharmacies and private hospitals.– Runs Clicks health and beauty stores and pharmacies in South Africa. It also operates specialist UniCare pharmacies and distributes medicines to pharmacies and private hospitals through UPD.– Sells medicines, beauty products and personal care goods through Clicks stores and pharmacies. Its UPD business supplies pharmacies and hospitals.– Runs Clicks pharmacies and stores and distributes medicines to pharmacies and private hospitals through UPD.ZA_CLS
Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.
Shares: connector/market_inputs
No confirmed data
To dividends →Monetary columns are in M USD, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.
| Date | Period | Status | RevenueM USD | Operating profitM USD | D&AM USD | EBITDAM USD | Net profitM USD | Operating CFM USD | Capex + M&AM USD | AssetsM USD | EquityM USD | ROE (annualized) | Net debtM USD | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-31 | H2 2026 (6M) | OK | 1564.4 y/y 13.4% | 162.0 y/y 12.8% | 64.3 y/y 37.8% | 226.3 y/y 18.9% | 109.6 y/y 9.0% | 229.9 | -52.1 | 1507.7 y/y 18.4% | 425.3 y/y 10.0% | 50.2% | 136.7 | Link |
| 2026-02-28 | H1 2026 (6M) | OK | 1481.5 y/y 23.4% | 134.2 y/y 23.4% | 59.8 y/y 25.8% | 194.0 y/y 24.2% | 91.1 y/y 22.5% | 62.5 | -19.1 | 1443.1 y/y 28.5% | 382.6 y/y 10.3% | 49.1% | 199.3 | Link |
| 2025-08-31 | H2 2025 (6M) | OK | 1363.6 y/y 4.1% | 142.3 y/y 11.4% | 45.9 y/y -7.0% | 188.2 y/y 6.2% | 99.6 y/y 15.0% | 235.4 | -42.1 | 1273.8 y/y 7.8% | 386.7 y/y 8.4% | 48.4% | 44.4 | Link |
| 2025-02-28 | H1 2025 (6M) | OK | 1281.1 y/y 7.4% | 116.0 y/y 13.9% | 50.7 y/y 8.8% | 166.7 y/y 12.3% | 79.4 y/y 14.1% | 54.4 | -11.9 | 1123.3 y/y 16.6% | 346.7 y/y 27.9% | 43.8% | 128.7 | Link |
| 2024-08-31 | H2 2024 (6M) | OK | 1283.9 y/y 11.3% | 125.6 y/y 17.9% | 48.4 y/y 17.6% | 173.9 y/y 17.8% | 85.0 y/y 14.6% | 100.9 | -31.7 | 1181.4 y/y 16.6% | 356.7 y/y 12.4% | 49.1% | 61.4 | Link |
| 2024-02-29 | H1 2024 (6M) | OK | 1162.6 y/y 1.5% | 99.3 y/y 5.6% | 45.4 y/y 6.2% | 144.7 y/y 5.8% | 67.8 y/y 2.8% | 61.3 | -16.6 | 962.9 y/y 1.5% | 271.2 y/y -12.8% | 45.9% | 147.7 | Link |
| 2023-08-31 | H2 2023 (6M) | OK | 1168.5 y/y — | 107.6 y/y — | 41.8 y/y — | 149.3 y/y — | 74.9 y/y — | 126.0 | -31.3 | 1013.1 y/y — | 317.5 y/y — | 44.5% | 41.7 | Link |
| 2023-02-28 | H1 2023 (6M) | OK | 1138.6 y/y — | 93.4 y/y — | 42.5 y/y — | 135.9 y/y — | 65.6 y/y — | 55.7 | -20.0 | 948.4 y/y — | 311.1 y/y — | — | 112.7 | Link |
| Debt (loans, bonds and leases) | 281 |
| − Cash & equivalents | 144 |
| Net debt | 137 |
|---|
Net debt / LTM EBITDA: 0.3x
Conversion to USD. Balance sheet: rate effective on 2026-08-31, fixing date unspecified. Flows: sampled average at each calculation period's bounds and monthly 15ths. Latest source row: 2026-01-01 — 2026-08-31. Source: Frankfurter historical request.
Half-year values ($ mln)
Year-over-year change
Operating and investing cash flow (OCF + ICF) ($ mln)
Net debt / cash ($ mln)
| year | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| cash flow / profit | 0.73x | 1.30x | 1.06x | 1.62x | 1.45x |
| accruals, % of assets | 4.0% | -4.1% | -0.8% | -8.9% | -6.2% |
Our earnings breakdowns and investment notes on this issuer.
Value the company creates per year, as a % of market cap
Value created per year: +16.0%
| 1. EBITDA growth (latest quarter YoY, annualised) [EBITDA latest qtr − EBITDA year-ago qtr] × annualisation X (2026-08-31 vs 2025-08-31) = (226 − 188) × 1.86 | 71 |
| 2. Current EV/EBITDA (LTM) (Market cap + Net debt) ÷ EBITDA (LTM) = (2 658 + 137) ÷ 420 | 6.6x |
| 3. Target multiple (Current EV/EBITDA + 8) ÷ 2 = (6.6 + 8) ÷ 2 | 7.3x |
| 4. Cash flow (balance method, LTM) Net-debt reduction + dividends + buybacks − equity issuance = -92 + 0 + 0 − 0 | -92 |
| 5. Value created per year (EBITDA growth × Target multiple + Cash flow − Dilution) ÷ Market cap = (71 × 7.3 + -92) ÷ 2 658 | +16.0% |
Amounts in millions of the reporting currency. EBITDA growth is the latest quarter vs the same quarter a year ago, annualised.
Caveats:
No confirmed data
| Date | Per share | Details | Status | Source |
|---|---|---|---|---|
| 2026-07-01 | 258 ZAR | Ex-dividend: 258 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2026-01-21 | 648 ZAR | Ex-dividend: 648 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2025-07-02 | 238 ZAR | Ex-dividend: 238 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2025-01-22 | 566 ZAR | Ex-dividend: 566 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2024-06-26 | 210 ZAR | Ex-dividend: 210 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2024-01-24 | 494 ZAR | Ex-dividend: 494 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2023-06-28 | 185 ZAR | Ex-dividend: 185 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2023-01-25 | 457 ZAR | Ex-dividend: 457 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2022-06-29 | 180 ZAR | Ex-dividend: 180 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2022-01-26 | 347.5 ZAR | Ex-dividend: 347.5 ZAR per share | Paid | Yahoo Finance (ex-div) |
KASE: status follows wording in the news headline (paid vs intends to pay). Yahoo: amounts are cash dividends per share on ex-dividend dates (UTC calendar date). stockscope.uz (UZ): amounts are per share in UZS by publication date (not necessarily ex-div).
Investor reporting (IR): https://www.clicksgroup.co.za/investors/
Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)
Financial results, valuation multiples (P/E, P/B, EV/EBITDA), profitability and dividend yield of Clicks Group (CLS) — from primary filings.
See also: South African Stocks (2026): Gold, Cheap Banks and the JSE Discount · The Cheapest Stocks in the World (2026): What Value Investing Says About Buying Cheap · global valuation map